Development of Dendritic Cell-Based Genetic Vaccines for Cancer
- 1 January 1997
- book chapter
- Published by Springer Nature
- Vol. 417, 511-518
- https://doi.org/10.1007/978-1-4757-9966-8_84
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Human tumor antigens recognized by T lymphocytes.The Journal of Experimental Medicine, 1996
- Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.The Journal of Experimental Medicine, 1996
- Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.The Journal of Experimental Medicine, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.The Journal of Experimental Medicine, 1996
- Dendritic cells: a major story unfoldsImmunology Today, 1995
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsNature, 1992
- Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.The Journal of Experimental Medicine, 1992
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988